Search Results
Kazia Therapeutics webinar - Combating childhood brain cancer
Kazia Therapeutics’ oncology drug paxalisib continues to generate positive trial data
Due Diligence Webinar - Kazia Therapeutics
Kazia Therapeutics: Edison Open House Healthcare 2022
Interview with Dr Matt Dun on DIPG research and GDC-0084
Kazia Shareholder Update - positive interim data from paxalisib phase II trial
Novel Designs for Brain Tumor Clinical Trials
KZIA stock KZIA Kazia Therapeutics Top stocks to buy in Sept
Kazia Therapeutics CEO hails Fast Track Designation for Paxalisib
Al Musella's Plan to Speed Up The Search For The Cure of Brain Tumors!
Onc201
Dr. Dun discusses his innovative trial funded by the DIPG/DMG Collaborative
